JPS6134428B2 - - Google Patents
Info
- Publication number
- JPS6134428B2 JPS6134428B2 JP53058470A JP5847078A JPS6134428B2 JP S6134428 B2 JPS6134428 B2 JP S6134428B2 JP 53058470 A JP53058470 A JP 53058470A JP 5847078 A JP5847078 A JP 5847078A JP S6134428 B2 JPS6134428 B2 JP S6134428B2
- Authority
- JP
- Japan
- Prior art keywords
- fluorouracil
- compound
- formula
- general formula
- chloroform
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5847078A JPS54151988A (en) | 1978-05-17 | 1978-05-17 | 55fluorouracil derivative*its manufacture and antiitumor drug containing it |
| BE78190883A BE870982A (fr) | 1978-05-17 | 1978-10-03 | Derives de 5-fluorouracile, leur preparation et leur utilisation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5847078A JPS54151988A (en) | 1978-05-17 | 1978-05-17 | 55fluorouracil derivative*its manufacture and antiitumor drug containing it |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS54151988A JPS54151988A (en) | 1979-11-29 |
| JPS6134428B2 true JPS6134428B2 (online.php) | 1986-08-07 |
Family
ID=13085309
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP5847078A Granted JPS54151988A (en) | 1978-05-17 | 1978-05-17 | 55fluorouracil derivative*its manufacture and antiitumor drug containing it |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPS54151988A (online.php) |
| BE (1) | BE870982A (online.php) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5719132A (en) * | 1996-06-27 | 1998-02-17 | Bristol-Myers Squibb Company | Compositions and methods of treating HIV with d4T, 5-fluorouracil/tegafur, and uracil |
-
1978
- 1978-05-17 JP JP5847078A patent/JPS54151988A/ja active Granted
- 1978-10-03 BE BE78190883A patent/BE870982A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JPS54151988A (en) | 1979-11-29 |
| BE870982A (fr) | 1979-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4620008A (en) | Processes for the preparation of omeprazole and intermediates therefore | |
| AU668107B2 (en) | Oxygen substituted derivatives of nucleophile-nitric oxide adducts as nitric oxide donor prodrugs | |
| JP3510955B2 (ja) | 改良された抗ウイルス化合物 | |
| RU2142946C1 (ru) | Производные пиразола и фармацевтическая композиция, содержащая их | |
| EP0599881B1 (en) | Gallium (iii) complexes, process for their obtention and pharmaceutical compositions containing them | |
| JPS6089474A (ja) | モルフイナン誘導体，その製造方法，及び該化合物を含有する抗腫瘍剤 | |
| EP0118913B1 (en) | Porphyrin derivatives | |
| JPS6026373B2 (ja) | 抗腸瘍剤 | |
| CN108794412B (zh) | 一种4,5-二芳基-2h-1,2,3-三唑化合物的制备方法 | |
| JP2707936B2 (ja) | β−オキソ−β−ベンゼンプロパンチオアミド誘導体 | |
| JPH0643421B2 (ja) | ピリミジン誘導体 | |
| JPH05117273A (ja) | 医薬化合物 | |
| JPS6134428B2 (online.php) | ||
| PL137949B1 (en) | Process for preparing novel substituted thiazolidinyl esters of inorganic acids | |
| EP3063158B1 (en) | Metallocene derivatives with anticancer activity | |
| CN114933601A (zh) | 汉防己甲素衍生物及其制备方法和应用 | |
| EP0378706B1 (en) | 5-substituted uridine derivatives and intermediates for their preparation | |
| WO1999059961A1 (en) | Selective anti-mycobacterial preparations, method for producing the same and pharmaceutical compositions | |
| CN113387934B (zh) | 一种多芳基取代咪唑衍生物及其制备方法与应用 | |
| US5420117A (en) | 5-substituted uridine derivatives | |
| US6017923A (en) | Carbo-acyclic nucleoside derivatives as antiviral and antineoplastic agents | |
| EP0713865A1 (fr) | Dérivés d'acide 2-aminobenzènesulfonique et de chlorure de 2-aminobenzènesulfonyle, leur préparation et leur utilisation comme intermédiaires de synthèse | |
| JPS6153352B2 (online.php) | ||
| JPS61152660A (ja) | ビス−ジオキソピペラジン誘導体 | |
| JPH06172365A (ja) | １０−チアイソアロキサジン誘導体およびその用途 |